메뉴 건너뛰기




Volumn 24, Issue 3, 2012, Pages 290-308

Agomelatine in depressive disorders: Its novel mechanisms of action

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MONOAMINE OXIDASE A INHIBITOR; PAROXETINE; RAMELTEON; SALBUTAMOL; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE; VOFOPITANT;

EID: 84867492657     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11090216     Document Type: Article
Times cited : (46)

References (186)
  • 2
    • 0014951460 scopus 로고
    • The switch process from depression to mania: Relationship to drugs which alter brain amines
    • Bunney WE Jr, Murphy DL, Goodwin FK, et al: The switch process from depression to mania: relationship to drugs which alter brain amines. Lancet 1970; 1:1022-1027
    • (1970) Lancet , vol.1 , pp. 1022-1027
    • Bunney Jr., W.E.1    Murphy, D.L.2    Goodwin, F.K.3
  • 3
    • 0029953520 scopus 로고    scopus 로고
    • Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression
    • Sonntag A, Rothe B, Guldner J, et al: Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 1996; 4:1-13
    • (1996) Depression , vol.4 , pp. 1-13
    • Sonntag, A.1    Rothe, B.2    Guldner, J.3
  • 5
    • 4444260616 scopus 로고    scopus 로고
    • The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
    • Celada P, Puig M, Amargós-Bosch M, et al: The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 2004; 29:252-265
    • (2004) J Psychiatry Neurosci , vol.29 , pp. 252-265
    • Celada, P.1    Puig, M.2    Amargós-Bosch, M.3
  • 6
    • 0037212076 scopus 로고    scopus 로고
    • Place of chronic insomnia in the course of depressive and anxiety disorders
    • Ohayon MM, Roth T: Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 2003; 37:9-15
    • (2003) J Psychiatr Res , vol.37 , pp. 9-15
    • Ohayon, M.M.1    Roth, T.2
  • 7
    • 0028105342 scopus 로고
    • Sleep disorders and melatonin rhythms in elderly people
    • Haimov I, Laudon M, Zisapel N, et al: Sleep disorders and melatonin rhythms in elderly people. BMJ 1994; 309:167
    • (1994) BMJ , vol.309 , pp. 167
    • Haimov, I.1    Laudon, M.2    Zisapel, N.3
  • 8
    • 0032434461 scopus 로고    scopus 로고
    • Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleep-wake rhythm disorders
    • Rodenbeck A, Huether G, Rüther E, et al: Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleep-wake rhythm disorders. J Pineal Res 1998; 25:201-210
    • (1998) J Pineal Res , vol.25 , pp. 201-210
    • Rodenbeck, A.1    Huether, G.2    Rüther, E.3
  • 9
    • 0346727185 scopus 로고    scopus 로고
    • Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy
    • LegerD, LaudonM, Zisapel N:Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 2004; 116:91-95
    • (2004) Am J Med , vol.116 , pp. 91-95
    • Leger, D.1    Laudon, M.2    Zisapel, N.3
  • 10
    • 0031870926 scopus 로고    scopus 로고
    • Melatonin for the treatment of sleep disturbances in major depressive disorder
    • Dolberg OT, Hirschmann S, Grunhaus L: Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998; 155:1119-1121
    • (1998) Am J Psychiatry , vol.155 , pp. 1119-1121
    • Dolberg, O.T.1    Hirschmann, S.2    Grunhaus, L.3
  • 11
    • 0041932292 scopus 로고    scopus 로고
    • The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2c receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways
    • Millan MJ, Gobert A, Lejeune E, et al: The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2c receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. Pharmacol Exp Ther 2003; 306:954-964
    • (2003) Pharmacol Exp Ther , vol.306 , pp. 954-964
    • Millan, M.J.1    Gobert, A.2    Lejeune, E.3
  • 12
    • 0012579495 scopus 로고    scopus 로고
    • Antidepressant-like action of S-20098 (agomelatine) in the learned helplessness test
    • Bertaina-Anglade V, Mocaer E, Drieu La Rochelle C: Antidepressant-like action of S-20098 (agomelatine) in the learned helplessness test. Int J Neuropsychopharmacol 2002; 5(suppl1):S65
    • (2002) Int J Neuropsychopharmacol , vol.5 , Issue.SUPPL.1
    • Bertaina-Anglade, V.1    Mocaer, E.2    Drieu La Rochelle, C.3
  • 13
    • 70349570733 scopus 로고    scopus 로고
    • Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: A 24-week randomized, doubleblind, placebo-controlled trial
    • Agomelatine Study Group
    • Goodwin GM, Emsley R, Rembry S, et al; Agomelatine Study Group: Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, doubleblind, placebo-controlled trial. J Clin Psychiatry 2009; 70:1128-1137
    • (2009) J Clin Psychiatry , vol.70 , pp. 1128-1137
    • Goodwin, G.M.1    Emsley, R.2    Rembry, S.3
  • 14
    • 0036738228 scopus 로고    scopus 로고
    • D' haenen H: Determination of the dose of agomelatine, a melatonergic agonist and selective 5-HT (2C) antagonist, in the treatment of major depressive disorder: A placebo-controlled dose range study
    • Loo H, Hale A: D' haenen H: Determination of the dose of agomelatine, a melatonergic agonist and selective 5-HT (2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Psychopharmacology (Berl) 2002; 17:239-247
    • (2002) Psychopharmacology (Berl) , vol.17 , pp. 239-247
    • Loo, H.1    Hale, A.2
  • 15
    • 31344471423 scopus 로고    scopus 로고
    • Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
    • Kennedy SH, Emsley R: Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol 2006; 16:93-100
    • (2006) Eur Neuropsychopharmacol , vol.16 , pp. 93-100
    • Kennedy, S.H.1    Emsley, R.2
  • 18
    • 0015173259 scopus 로고
    • Melatonin metabolism: Neural regulation of pineal serotonin: Acetyl coenzyme A Nacetyltransferase activity
    • Klein DC, Weller JL, Moore RY: Melatonin metabolism: neural regulation of pineal serotonin: acetyl coenzyme A Nacetyltransferase activity. Proc Natl Acad Sci USA 1971; 68:3107-3110
    • (1971) Proc Natl Acad Sci USA , vol.68 , pp. 3107-3110
    • Klein, D.C.1    Weller, J.L.2    Moore, R.Y.3
  • 19
    • 0015124725 scopus 로고
    • Metabolism of serotonin by the rat retina in vitro
    • Cardinali DP, Rosner JM: Metabolism of serotonin by the rat retina in vitro. J Neurochem 1971; 18:1769-1770
    • (1971) J Neurochem , vol.18 , pp. 1769-1770
    • Cardinali, D.P.1    Rosner, J.M.2
  • 20
    • 0036798932 scopus 로고    scopus 로고
    • Gastrointestinal melatonin: Localization, function, and clinical relevance
    • Bubenik GA: Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47:2336-2348
    • (2002) Dig Dis Sci , vol.47 , pp. 2336-2348
    • Bubenik, G.A.1
  • 21
    • 27644587826 scopus 로고    scopus 로고
    • On the role of melatonin in skin physiology and pathology
    • Slominski A, Fischer TW, Zmijewski MA, et al: On the role of melatonin in skin physiology and pathology. Endocrine 2005; 27:137-148
    • (2005) Endocrine , vol.27 , pp. 137-148
    • Slominski, A.1    Fischer, T.W.2    Zmijewski, M.A.3
  • 22
    • 2442648067 scopus 로고    scopus 로고
    • Evidence of melatonin synthesis by human lymphocytes and its physiological significance: Possible role as intracrine, autocrine, and/or paracrine substance
    • Carrillo-Vico A, Calvo JR, Abreu P, et al: Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 2004; 18:537-539
    • (2004) FASEB J , vol.18 , pp. 537-539
    • Carrillo-Vico, A.1    Calvo, J.R.2    Abreu, P.3
  • 23
    • 33947493911 scopus 로고    scopus 로고
    • Melatonin biosynthesis in the thymus of humans and rats
    • Naranjo MC, Guerrero JM, Rubio A, et al: Melatonin biosynthesis in the thymus of humans and rats. Cell Mol Life Sci 2007; 64:781-790
    • (2007) Cell Mol Life Sci , vol.64 , pp. 781-790
    • Naranjo, M.C.1    Guerrero, J.M.2    Rubio, A.3
  • 24
    • 0642277241 scopus 로고    scopus 로고
    • Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod
    • Tricoire H, Møller M, Chemineau P, et al: Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod. Reprod Suppl 2003; 61:311-321
    • (2003) Reprod Suppl , vol.61 , pp. 311-321
    • Tricoire, H.1    Møller, M.2    Chemineau, P.3
  • 25
    • 11844277100 scopus 로고    scopus 로고
    • The basic physiology and pathophysiology of melatonin
    • Claustrat B, Brun J, Chazot G: The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005; 9:11-24
    • (2005) Sleep Med Rev , vol.9 , pp. 11-24
    • Claustrat, B.1    Brun, J.2    Chazot, G.3
  • 26
    • 0015944572 scopus 로고
    • In-vitro and in-vivo formation of two new metabolites of melatonin
    • Hirata F, Hayaishi O, Tokuyama T, et al: In-vitro and in-vivo formation of two new metabolites of melatonin. J Biol Chem 1974; 249:1311-1313
    • (1974) J Biol Chem , vol.249 , pp. 1311-1313
    • Hirata, F.1    Hayaishi, O.2    Tokuyama, T.3
  • 27
    • 0028018966 scopus 로고
    • Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses
    • Reppert SM, Weaver DR, Ebisawa T: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13:1177-1185
    • (1994) Neuron , vol.13 , pp. 1177-1185
    • Reppert, S.M.1    Weaver, D.R.2    Ebisawa, T.3
  • 28
    • 0029115639 scopus 로고
    • Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor
    • Reppert SM, Godson C, Mahle CD, et al: Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92:8734-8738
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 8734-8738
    • Reppert, S.M.1    Godson, C.2    Mahle, C.D.3
  • 29
    • 0033346394 scopus 로고    scopus 로고
    • Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins
    • Brydon L, Roka F, Petit L, et al: Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol Endocrinol 1999; 13:2025-2038
    • (1999) Mol Endocrinol , vol.13 , pp. 2025-2038
    • Brydon, L.1    Roka, F.2    Petit, L.3
  • 30
    • 22844439551 scopus 로고    scopus 로고
    • Molecular tools to study melatonin pathways and actions
    • Boutin JA, Audinot V, Ferry G, et al: Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 2005; 26:412-419
    • (2005) Trends Pharmacol Sci , vol.26 , pp. 412-419
    • Boutin, J.A.1    Audinot, V.2    Ferry, G.3
  • 31
    • 65649123794 scopus 로고    scopus 로고
    • Melatonin and melatonergic drugs on sleep: Possible mechanisms of action
    • Srinivasan V, Pandi-Perumal SR, Trahkt I, et al: Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci 2009; 119:821-846
    • (2009) Int J Neurosci , vol.119 , pp. 821-846
    • Srinivasan, V.1    Pandi-Perumal, S.R.2    Trahkt, I.3
  • 32
    • 0019429224 scopus 로고
    • Sleep and treatment prediction in endogenous depression
    • Kupfer DJ, Spiker DG, Coble PA, et al: Sleep and treatment prediction in endogenous depression. Am J Psychiatry 1981; 138:429-434
    • (1981) Am J Psychiatry , vol.138 , pp. 429-434
    • Kupfer, D.J.1    Spiker, D.G.2    Coble, P.A.3
  • 33
    • 0034944551 scopus 로고    scopus 로고
    • Sleep and depression: A challenge for anti-depresaants, an overview
    • Riemann D, Berger M, Voderholzer U: Sleep and depression: a challenge for anti-depresaants, an overview. Biol Psychol 2001; 57:67-103
    • (2001) Biol Psychol , vol.57 , pp. 67-103
    • Riemann, D.1    Berger, M.2    Voderholzer, U.3
  • 34
    • 33846329106 scopus 로고    scopus 로고
    • Sleep and circadian rhythms in mood disorders
    • Armitage R: Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand Suppl 2007; (433):104-115
    • (2007) Acta Psychiatr Scand Suppl , Issue.433 , pp. 104-115
    • Armitage, R.1
  • 35
    • 0024448838 scopus 로고
    • Epidemiologic study of sleep disturbances and psychiatric disorders
    • Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989; 262:1479-1484
    • (1989) An opportunity for prevention? JAMA , vol.262 , pp. 1479-1484
    • Ford, D.E.1    Kamerow, D.B.2
  • 36
    • 33646689322 scopus 로고    scopus 로고
    • Sleep disturbances and depression: A challenge for antidepressants
    • Lam RW: Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol 2006; 21(Suppl 1): S25-S29
    • (2006) Int Clin Psychopharmacol , vol.21 , Issue.SUPPL. 1
    • Lam, R.W.1
  • 37
    • 0034095861 scopus 로고    scopus 로고
    • Depression and insomnia: Questions of cause and effect
    • Lustberg L, Reynolds CF: Depression and insomnia: questions of cause and effect. Sleep Med Rev 2000; 4:253-262
    • (2000) Sleep Med Rev , vol.4 , pp. 253-262
    • Lustberg, L.1    Reynolds, C.F.2
  • 38
    • 67650594924 scopus 로고    scopus 로고
    • Bidirectional communication between sleep and circadian rhythms and its implications for depression: Lessons from agomelatine
    • Pandi-Perumal SR, Moscovitch A, Srinivasan V, et al: Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine. Prog Neurobiol 2009; 88:264-271
    • (2009) Prog Neurobiol , vol.88 , pp. 264-271
    • Pandi-Perumal, S.R.1    Moscovitch, A.2    Srinivasan, V.3
  • 39
    • 84859700294 scopus 로고    scopus 로고
    • Sleep, mood disorders and antidepressants: Themelatonergic anti-depressant agomelatine offers a new strategy of treatment
    • Srinivasan V, Brzezinski A, Spence DW, et al: Sleep, mood disorders and antidepressants: themelatonergic anti-depressant agomelatine offers a new strategy of treatment. Psychiatr Fenn 2010; 41:168-187
    • (2010) Psychiatr Fenn , vol.41 , pp. 168-187
    • Srinivasan, V.1    Brzezinski, A.2    Spence, D.W.3
  • 40
    • 33749527675 scopus 로고    scopus 로고
    • Depression and associated sleep disturbances: Patient's benefits with agomelatine
    • Kupfer DJ: Depression and associated sleep disturbances: patient's benefits with agomelatine. Eur Neuropsychopharmacol 2006; 16(suppl5): S 639-S643
    • (2006) Eur Neuropsychopharmacol , vol.16 , Issue.SUPPL.5
    • Kupfer, D.J.1
  • 41
    • 33845909859 scopus 로고    scopus 로고
    • Pharmacotherapy of bipolar depression: An update
    • Thase ME: Pharmacotherapy of bipolar depression: an update. Curr Psychiatry Rep 2006; 8:478-488
    • (2006) Curr Psychiatry Rep , vol.8 , pp. 478-488
    • Thase, M.E.1
  • 42
    • 33947653784 scopus 로고    scopus 로고
    • Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies
    • Ruhé HG, Mason NS, Schene AH: Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 2007; 12:331-359
    • (2007) Mol Psychiatry , vol.12 , pp. 331-359
    • Ruhé, H.G.1    Mason, N.S.2    Schene, A.H.3
  • 43
    • 33646686569 scopus 로고    scopus 로고
    • Efficacy and tolerance profile of agomelatine and practical use in depressed patients
    • Rouillon F: Efficacy and tolerance profile of agomelatine and practical use in depressed patients. Int Clin Psychopharmacol 2006; 21(Suppl 1):S31-S35
    • (2006) Int Clin Psychopharmacol , vol.21 , Issue.SUPPL. 1
    • Rouillon, F.1
  • 44
    • 0026628711 scopus 로고
    • Novel naphthalenic ligands with high affinity for the melatonin receptor
    • Yous S, Andrieux J, Howell HE, et al: Novel naphthalenic ligands with high affinity for the melatonin receptor. J Med Chem 1992; 35:1484-1486
    • (1992) J Med Chem , vol.35 , pp. 1484-1486
    • Yous, S.1    Andrieux, J.2    Howell, H.E.3
  • 45
    • 0033692454 scopus 로고    scopus 로고
    • Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling
    • Bogaards JJ, Hissink EM, Briggs M, et al: Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling. Eur J Pharm Sci 2000; 12:117-124
    • (2000) Eur J Pharm Sci , vol.12 , pp. 117-124
    • Bogaards, J.J.1    Hissink, E.M.2    Briggs, M.3
  • 46
    • 0027081914 scopus 로고
    • Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression
    • Pepin MC, Pothier F, Barden N: Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 1992; 42:991-995
    • (1992) Mol Pharmacol , vol.42 , pp. 991-995
    • Pepin, M.C.1    Pothier, F.2    Barden, N.3
  • 47
    • 0242575035 scopus 로고    scopus 로고
    • Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats
    • Chagraoui A, Protais P, Filloux T, et al: Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats. Psychopharmacology (Berl) 2003; 170:17-22
    • (2003) Psychopharmacology (Berl) , vol.170 , pp. 17-22
    • Chagraoui, A.1    Protais, P.2    Filloux, T.3
  • 48
    • 1642285042 scopus 로고    scopus 로고
    • Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems
    • Giorgetti M, Tecott LH: Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. Eur J Pharmacol 2004; 488:1-9
    • (2004) Eur J Pharmacol , vol.488 , pp. 1-9
    • Giorgetti, M.1    Tecott, L.H.2
  • 49
    • 2342459611 scopus 로고    scopus 로고
    • Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: Involvement of melatonin and serotonin receptors
    • Bourin M, Mocaër E, Porsolt R: Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 2004; 29:126-133
    • (2004) J Psychiatry Neurosci , vol.29 , pp. 126-133
    • Bourin, M.1    Mocaër, E.2    Porsolt, R.3
  • 50
    • 0018268297 scopus 로고
    • Behavioural despair in rats: A new model sensitive to antidepressant treatments
    • Porsolt RD, Anton G, Blavet N, et al: Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 47:379-391
    • (1978) Eur J Pharmacol , vol.47 , pp. 379-391
    • Porsolt, R.D.1    Anton, G.2    Blavet, N.3
  • 51
    • 23144443533 scopus 로고    scopus 로고
    • Antidepressant action of agomelatine (S20098) in a transgenic mouse model
    • Barden N, Shink E, Labbe M, et al: Antidepressant action of agomelatine (S20098) in a transgenic mouse model. Prog Neuropsychopharmacol Biol Psychiat 2005; 29: 08-916
    • (2005) Prog Neuropsychopharmacol Biol Psychiat , vol.29 , pp. 08-916
    • Barden, N.1    Shink, E.2    Labbe, M.3
  • 52
    • 0038050606 scopus 로고    scopus 로고
    • Effect of agomelatine in the chronic mild stress model of depression in the rat
    • Papp M, Gruca P, Boyer PA, et al: Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 2003; 28:694-703
    • (2003) Neuropsychopharmacology , vol.28 , pp. 694-703
    • Papp, M.1    Gruca, P.2    Boyer, P.A.3
  • 53
    • 33646672157 scopus 로고    scopus 로고
    • Pharmacology of a new antidepressant: Benefit of the implication of the melatonergic system
    • Fuchs E, Simon M, Schmelting B: Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system. Int Clin Psychopharmacol 2006; 21(Suppl 1):S17-S20
    • (2006) Int Clin Psychopharmacol , vol.21 , Issue.SUPPL. 1
    • Fuchs, E.1    Simon, M.2    Schmelting, B.3
  • 54
    • 33751192681 scopus 로고    scopus 로고
    • Antidepressant-like effects of agomelatine (S 20098) in the learned helplessnessmodel
    • Bertaina-Anglade V, la Rochelle CD, Boyer PA, et al: Antidepressant-like effects of agomelatine (S 20098) in the learned helplessnessmodel. Behav Pharmacol 2006; 17:703-713
    • (2006) Behav Pharmacol , vol.17 , pp. 703-713
    • Bertaina-Anglade, V.1    la Rochelle, C.D.2    Boyer, P.A.3
  • 55
    • 0028916266 scopus 로고
    • Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms
    • Redman JR, Guardiola-Lemaitre B, Brown M, et al: Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms. Psychopharmacology (Berl) 1995; 118:385-390
    • (1995) Psychopharmacology (Berl) , vol.118 , pp. 385-390
    • Redman, J.R.1    Guardiola-Lemaitre, B.2    Brown, M.3
  • 56
    • 0027362397 scopus 로고
    • Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS)
    • Armstrong SM, McNulty OM, Guardiola-Lemaitre B, et al: Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS). Pharmacol Biochem Behav 1993; 46:45-49
    • (1993) Pharmacol Biochem Behav , vol.46 , pp. 45-49
    • Armstrong, S.M.1    McNulty, O.M.2    Guardiola-Lemaitre, B.3
  • 57
    • 0030218832 scopus 로고    scopus 로고
    • Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent
    • Martinet L, Guardiola-Lemaitre B, Mocaer E: Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacol Biochem Behav 1996; 54:713-718
    • (1996) Pharmacol Biochem Behav , vol.54 , pp. 713-718
    • Martinet, L.1    Guardiola-Lemaitre, B.2    Mocaer, E.3
  • 58
    • 0031989198 scopus 로고    scopus 로고
    • Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal
    • Redman JR, Francis AJ: Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal. J Biol Rhythms 1998; 13:39-51
    • (1998) J Biol Rhythms , vol.13 , pp. 39-51
    • Redman, J.R.1    Francis, A.J.2
  • 59
    • 0032834067 scopus 로고    scopus 로고
    • Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist
    • Pitrosky B, Kirsch R, Malan A, et al: Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist. Am J Physiol 1999; 277(3 Pt 2): R812-R828
    • (1999) Am J Physiol , vol.277 , Issue.3 PART 2
    • Pitrosky, B.1    Kirsch, R.2    Malan, A.3
  • 60
    • 0034644822 scopus 로고    scopus 로고
    • A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle
    • Weibel L, Turek FW, Mocaer E, et al: A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle. Brain Res 2000; 880:207-211
    • (2000) Brain Res , vol.880 , pp. 207-211
    • Weibel, L.1    Turek, F.W.2    Mocaer, E.3
  • 61
    • 24144461633 scopus 로고    scopus 로고
    • Phase-shifts of 24-hr rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men
    • Leproult R, Van Onderbergen A, L'hermite-Balériaux M, et al: Phase-shifts of 24-hr rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol (Oxf) 2005; 63:298-304
    • (2005) Clin Endocrinol (Oxf) , vol.63 , pp. 298-304
    • Leproult, R.1    Van Onderbergen, A.2    L'hermite-Balériaux, M.3
  • 62
    • 16844380632 scopus 로고    scopus 로고
    • Social stress in tree shrews as an animal model of depression: An example of a behavioral model of a CNS disorder
    • Fuchs E: Social stress in tree shrews as an animal model of depression: an example of a behavioral model of a CNS disorder. CNS Spectr 2005; 10:182-190
    • (2005) CNS Spectr , vol.10 , pp. 182-190
    • Fuchs, E.1
  • 63
    • 33745669873 scopus 로고    scopus 로고
    • Effects of melatonin and agomelatine in anxiety-related procedures in rats: Interaction with diazepam
    • Loiseau F, Le Bihan C, Hamon M, et al: Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam. Eur Neuropsychopharmacol 2006; 16:417-428
    • (2006) Eur Neuropsychopharmacol , vol.16 , pp. 417-428
    • Loiseau, F.1    Le Bihan, C.2    Hamon, M.3
  • 64
    • 84861462398 scopus 로고    scopus 로고
    • Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety
    • Rainer Q, Xia L, Guilloux JP, et al: Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. Int J Neuropsychopharmacol 2011; 8:1-15
    • (2011) Int J Neuropsychopharmacol , vol.8 , pp. 1-15
    • Rainer, Q.1    Xia, L.2    Guilloux, J.P.3
  • 65
    • 2542484527 scopus 로고    scopus 로고
    • A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors
    • Bannerman DM, Deacon RM, Brady S, et al: A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors. Behav Neurosci 2004; 118:643-647
    • (2004) Behav Neurosci , vol.118 , pp. 643-647
    • Bannerman, D.M.1    Deacon, R.M.2    Brady, S.3
  • 66
    • 73549123839 scopus 로고    scopus 로고
    • Are the dorsal and ventral hippocampus functionally distinct structures?
    • Fanselow MS, Dong HW: Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 2010; 65:7-19
    • (2010) Neuron , vol.65 , pp. 7-19
    • Fanselow, M.S.1    Dong, H.W.2
  • 67
    • 37049039648 scopus 로고    scopus 로고
    • Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: Randomized, double-blind comparison with venlafaxine
    • Lemoine P, Guilleminault C, Alvarez E: Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J Clin Psychiatry 2007; 68: 1723-1732
    • (2007) J Clin Psychiatry , vol.68 , pp. 1723-1732
    • Lemoine, P.1    Guilleminault, C.2    Alvarez, E.3
  • 68
    • 0035377092 scopus 로고    scopus 로고
    • Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments
    • CANMAT Depression Work Group
    • Kennedy SH, Lam RW, Cohen NL, et al; CANMAT Depression Work Group: Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry 2001; 46(Suppl 1):38S-58S
    • (2001) Can J Psychiatry , vol.46 , Issue.SUPPL. 1
    • Kennedy, S.H.1    Lam, R.W.2    Cohen, N.L.3
  • 69
    • 0035030238 scopus 로고    scopus 로고
    • Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: A comparison with fluvoxamine
    • Milnacipran/Fluvoxamine Study Group
    • Clerc G; Milnacipran/Fluvoxamine Study Group: Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine. Int Clin Psychopharmacol 2001; 16:145-151
    • (2001) Int Clin Psychopharmacol , vol.16 , pp. 145-151
    • Clerc, G.1
  • 70
    • 51449112441 scopus 로고    scopus 로고
    • A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR
    • Kennedy SH, Rizvi S, Fulton K, et al: A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 2008; 28:329-333
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 329-333
    • Kennedy, S.H.1    Rizvi, S.2    Fulton, K.3
  • 71
    • 79955669643 scopus 로고    scopus 로고
    • Major depressive disorder, anhedonia and agomelatine: An openlabel study
    • Di Giannantonio M, Di Iorio G, Guglielmo R, et al: Major depressive disorder, anhedonia and agomelatine: an openlabel study. J Biol Regul Homeost Agents 2011; 25:109-114
    • (2011) J Biol Regul Homeost Agents , vol.25 , pp. 109-114
    • Di Giannantonio, M.1    Di Iorio, G.2    Guglielmo, R.3
  • 72
    • 34548446414 scopus 로고    scopus 로고
    • Agomelatine Bipolar Study Group: Agomelatine adjunctive therapy for acute bipolar depression: Preliminary open data
    • Calabrese JR, Guelfi JD, Perdrizet-Chevallier C: Agomelatine Bipolar Study Group: Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. Bipolar Disord 2007; 9:628-635
    • (2007) Bipolar Disord , vol.9 , pp. 628-635
    • Calabrese, J.R.1    Guelfi, J.D.2    Perdrizet-Chevallier, C.3
  • 73
    • 33846815170 scopus 로고    scopus 로고
    • Agomelatine in the treatment of seasonal affective disorder
    • Pjrek E, Winkler D, Konstantinidis A, et al: Agomelatine in the treatment of seasonal affective disorder. Psychopharmacology (Berl) 2007; 190:575-579
    • (2007) Psychopharmacology (Berl) , vol.190 , pp. 575-579
    • Pjrek, E.1    Winkler, D.2    Konstantinidis, A.3
  • 74
    • 78549269430 scopus 로고    scopus 로고
    • A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation
    • Fornaro M, Prestia D, Colicchio S, et al: A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Curr Neuropharmacol 2010; 8:287-304
    • (2010) Curr Neuropharmacol , vol.8 , pp. 287-304
    • Fornaro, M.1    Prestia, D.2    Colicchio, S.3
  • 75
    • 58149129754 scopus 로고    scopus 로고
    • Efficacy of agomelatine in generalized anxiety disorder: A randomized, double-blind, placebo-controlled study
    • Stein DJ, Ahokas AA, de Bodinat C: Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2008; 28:561-566
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 561-566
    • Stein, D.J.1    Ahokas, A.A.2    de Bodinat, C.3
  • 76
    • 80054744194 scopus 로고    scopus 로고
    • Possibilities of preventive treatment of migraine with the MT1-and MT2 agonist and 5-HT2c receptor antagonist agomelatin (valdoxan)
    • Tabeeva GR, Sergeev AV, Gromova SA: [Possibilities of preventive treatment of migraine with the MT1-and MT2 agonist and 5-HT2c receptor antagonist agomelatin (valdoxan)]. Zh Nevrol Psikhiatr Im S S Korsakova 2011; 111:32-36
    • (2011) Zh Nevrol Psikhiatr Im S S Korsakova , vol.111 , pp. 32-36
    • Tabeeva, G.R.1    Sergeev, A.V.2    Gromova, S.A.3
  • 77
    • 84855344910 scopus 로고    scopus 로고
    • Agomelatine improves sleep in patient with Fatal Familial Insomnia
    • Fibrose T, Skwik FI, Schreiner R, et al: Agomelatine improves sleep in patient with Fatal Familial Insomnia. Pharmacopsychiatry 2011; 45(1):34-36
    • (2011) Pharmacopsychiatry , vol.45 , Issue.1 , pp. 34-36
    • Fibrose, T.1    Skwik, F.I.2    Schreiner, R.3
  • 78
    • 77952115305 scopus 로고    scopus 로고
    • Agomelatine in the treatment of major depressive disorder: Potential for clinical effectiveness
    • Kennedy SH, Rizvi SJ: Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness. CNS Drugs 2010; 24:479-499
    • (2010) CNS Drugs , vol.24 , pp. 479-499
    • Kennedy, S.H.1    Rizvi, S.J.2
  • 79
    • 0032958811 scopus 로고    scopus 로고
    • Effects of SSRIs on sexual function: A critical review
    • Rosen RC, Lane RM, Menza M: Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999; 19:67-85
    • (1999) J Clin Psychopharmacol , vol.19 , pp. 67-85
    • Rosen, R.C.1    Lane, R.M.2    Menza, M.3
  • 80
    • 33646702013 scopus 로고    scopus 로고
    • Sexual function in remitted depresse patient following agomelatine
    • Kennedy SH: Sexual function in remitted depresse patient following agomelatine. Eur Neuropsychopharmacol 2005; 15 (Supp. 3):S440
    • (2005) Eur Neuropsychopharmacol , vol.15 , Issue.SUPPL. 3
    • Kennedy, S.H.1
  • 81
    • 33745795154 scopus 로고    scopus 로고
    • Agomelatine targets a range of major depressive disorder symptoms
    • Dubocovitch ML: Agomelatine targets a range of major depressive disorder symptoms. Curr Opin Invest drugs 2006; 7: 670-680
    • (2006) Curr Opin Invest drugs , vol.7 , pp. 670-680
    • Dubocovitch, M.L.1
  • 82
    • 42749088762 scopus 로고    scopus 로고
    • Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro
    • Varcoe TJ, Kennaway DJ: Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro. Brain Res 2008; 1209:19-28
    • (2008) Brain Res , vol.1209 , pp. 19-28
    • Varcoe, T.J.1    Kennaway, D.J.2
  • 83
    • 0032219620 scopus 로고    scopus 로고
    • 5-HT2C receptor agonists: Pharmacological characteristics and therapeutic potential
    • Martin JR, Bös M, Jenck F, et al: 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 1998; 286:913-924
    • (1998) J Pharmacol Exp Ther , vol.286 , pp. 913-924
    • Martin, J.R.1    Bös, M.2    Jenck, F.3
  • 84
    • 35349020998 scopus 로고    scopus 로고
    • Limitations of current medical treatments for depression: Disturbed circadian rhythms as a possible therapeutic target
    • Lader M: Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target. Eur Neuropsychopharmacol 2007; 17:743-755
    • (2007) Eur Neuropsychopharmacol , vol.17 , pp. 743-755
    • Lader, M.1
  • 85
    • 34948910106 scopus 로고    scopus 로고
    • The interaction between the internal clock and antidepressant efficacy
    • Racagni G, Riva MA, Popoli M: The interaction between the internal clock and antidepressant efficacy. Int Clin Psychopharmacol 2007; 22(Suppl 2):S9-S14
    • (2007) Int Clin Psychopharmacol , vol.22 , Issue.SUPPL. 2
    • Racagni, G.1    Riva, M.A.2    Popoli, M.3
  • 86
    • 77950884687 scopus 로고    scopus 로고
    • Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients
    • Quera-Salva MA, Lemoine P, Guilleminault C: Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Hum Psychopharmacol 2010; 25:222-229
    • (2010) Hum Psychopharmacol , vol.25 , pp. 222-229
    • Quera-Salva, M.A.1    Lemoine, P.2    Guilleminault, C.3
  • 87
    • 34147173300 scopus 로고    scopus 로고
    • Circadian genes, rhythms and the biology of mood disorders
    • McClung CA: Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 2007; 114:222-232
    • (2007) Pharmacol Ther , vol.114 , pp. 222-232
    • McClung, C.A.1
  • 88
    • 34249883579 scopus 로고    scopus 로고
    • Challenging the omnipotence of the suprachiasmatic timekeeper: Are circadian oscillators present throughout the mammalian brain?
    • Guilding C, Piggins HD: Challenging the omnipotence of the suprachiasmatic timekeeper: are circadian oscillators present throughout the mammalian brain? Eur J Neurosci 2007; 25:3195-3216
    • (2007) Eur J Neurosci , vol.25 , pp. 3195-3216
    • Guilding, C.1    Piggins, H.D.2
  • 89
    • 0033603542 scopus 로고    scopus 로고
    • Stability, precision, and near-24-hour period of the human circadian pacemaker
    • Czeisler CA, Duffy JF, Shanahan TL, et al: Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999; 284:2177-2181
    • (1999) Science , vol.284 , pp. 2177-2181
    • Czeisler, C.A.1    Duffy, J.F.2    Shanahan, T.L.3
  • 90
    • 0018762961 scopus 로고
    • Neural regulation of circadian rhythms
    • Rusak B, Zucker I: Neural regulation of circadian rhythms. Physiol Rev 1979; 59:449-526
    • (1979) Physiol Rev , vol.59 , pp. 449-526
    • Rusak, B.1    Zucker, I.2
  • 91
    • 33846571948 scopus 로고    scopus 로고
    • Altered sleep/wake patterns and mental performance
    • Akerstedt T: Altered sleep/wake patterns and mental performance. Physiol Behav 2007; 90:209-218
    • (2007) Physiol Behav , vol.90 , pp. 209-218
    • Akerstedt, T.1
  • 92
    • 0029923655 scopus 로고    scopus 로고
    • Circadian rhythm adjustment: Difficulties in assessment caused by masking
    • Waterhouse J, Minors D, Akerstedt T, et al: Circadian rhythm adjustment: difficulties in assessment caused by masking. Pathol Biol (Paris) 1996; 44:205-207
    • (1996) Pathol Biol (Paris) , vol.44 , pp. 205-207
    • Waterhouse, J.1    Minors, D.2    Akerstedt, T.3
  • 93
    • 0030761518 scopus 로고    scopus 로고
    • Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock
    • Liu C, Weaver DR, Jin X, et al: Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19:91-102
    • (1997) Neuron , vol.19 , pp. 91-102
    • Liu, C.1    Weaver, D.R.2    Jin, X.3
  • 94
    • 0037304598 scopus 로고    scopus 로고
    • Targeted disruption of the mouse Mel(1b) melatonin receptor
    • Jin X, von Gall C, Pieschl RL, et al: Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 2003; 23:1054-1060
    • (2003) Mol Cell Biol , vol.23 , pp. 1054-1060
    • Jin, X.1    von Gall, C.2    Pieschl, R.L.3
  • 95
    • 59549093363 scopus 로고    scopus 로고
    • Pathophysiology of depression: Role of sleep and the melatonergic system
    • Srinivasan V, Pandi-Perumal SR, Trakht I, et al: Pathophysiology of depression: role of sleep and the melatonergic system. Psychiatry Res 2009; 165:201-214
    • (2009) Psychiatry Res , vol.165 , pp. 201-214
    • Srinivasan, V.1    Pandi-Perumal, S.R.2    Trakht, I.3
  • 96
    • 34948858413 scopus 로고    scopus 로고
    • Evidence of agomelatine's antidepressant efficacy: The key points
    • Eser D, Baghai TC, Möller HJ: Evidence of agomelatine's antidepressant efficacy: the key points. Int Clin Psychopharmacol 2007; 22(Suppl 2):S15-S19
    • (2007) Int Clin Psychopharmacol , vol.22 , Issue.SUPPL. 2
    • Eser, D.1    Baghai, T.C.2    Möller, H.J.3
  • 97
    • 79954633976 scopus 로고    scopus 로고
    • The emerging role of melatonin agonists in the treatment of major depression: Focus on agomelatine
    • De Berardis D, Di Iorio G, Acciavatti T, et al: The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine. CNS Neurol Disord Drug Targets 2011; 10:119-132
    • (2011) CNS Neurol Disord Drug Targets , vol.10 , pp. 119-132
    • De Berardis, D.1    Di Iorio, G.2    Acciavatti, T.3
  • 98
    • 78049520183 scopus 로고    scopus 로고
    • The antidepressant agomelatine improves the quality of life of depressed patients: Implications for remission
    • Llorca PM: The antidepressant agomelatine improves the quality of life of depressed patients: implications for remission. J Psychopharmacol 2010; 24(Suppl):21-26
    • (2010) J Psychopharmacol , vol.24 , Issue.SUPPL. , pp. 21-26
    • Llorca, P.M.1
  • 99
    • 84859701248 scopus 로고    scopus 로고
    • Melatonin agonists for treatment of sleep and depressive disorders
    • Srinivasan V, Cardinali DP, Pandi-Perumal SR, et al: Melatonin agonists for treatment of sleep and depressive disorders. J Exptl Integ Med 2011; 1:149-158
    • (2011) J Exptl Integ Med , vol.1 , pp. 149-158
    • Srinivasan, V.1    Cardinali, D.P.2    Pandi-Perumal, S.R.3
  • 100
    • 79960313397 scopus 로고    scopus 로고
    • Strategies to achieve clinical effectiveness: Refining existing therapies and pursuing emerging targets
    • Kennedy SH, Young AH, Blier P: Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets. J Affect Disord 2011; 132(Suppl 1):S21-S28
    • (2011) J Affect Disord , vol.132 , Issue.SUPPL. 1
    • Kennedy, S.H.1    Young, A.H.2    Blier, P.3
  • 101
    • 69949159287 scopus 로고    scopus 로고
    • Emerging drugs for major depressive disorder
    • Kennedy SH, Rizvi SJ: Emerging drugs for major depressive disorder. Expert Opin Emerg Drugs 2009; 14:439-453
    • (2009) Expert Opin Emerg Drugs , vol.14 , pp. 439-453
    • Kennedy, S.H.1    Rizvi, S.J.2
  • 102
    • 77955172537 scopus 로고    scopus 로고
    • Agomelatine, the first melatonergic antidepressant: Discovery, characterization and development
    • de Bodinat C, Guardiola-Lemaitre B, Mocaër E, et al: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 2010; 9:628-642
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 628-642
    • de Bodinat, C.1    Guardiola-Lemaitre, B.2    Mocaër, E.3
  • 103
    • 33744919791 scopus 로고    scopus 로고
    • Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
    • Banasr M, Soumier A, Hery M, et al: Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 2006; 59:1087-1096
    • (2006) Biol Psychiatry , vol.59 , pp. 1087-1096
    • Banasr, M.1    Soumier, A.2    Hery, M.3
  • 104
    • 70349142643 scopus 로고    scopus 로고
    • Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus
    • Soumier A, Banasr M, Lortet S, et al: Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology 2009; 34:2390-2403
    • (2009) Neuropsychopharmacology , vol.34 , pp. 2390-2403
    • Soumier, A.1    Banasr, M.2    Lortet, S.3
  • 105
    • 77957144923 scopus 로고    scopus 로고
    • Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptorimpaired mice
    • Païzanis E, Renoir T, Lelievre V, et al: Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptorimpaired mice. Int J Neuropsychopharmacol 2010; 13:759-774
    • (2010) Int J Neuropsychopharmacol , vol.13 , pp. 759-774
    • Païzanis, E.1    Renoir, T.2    Lelievre, V.3
  • 106
    • 0032434817 scopus 로고    scopus 로고
    • Functional differentiation in the hippocampus
    • Moser MB, Moser EI: Functional differentiation in the hippocampus. Hippocampus 1998; 8:608-619
    • (1998) Hippocampus , vol.8 , pp. 608-619
    • Moser, M.B.1    Moser, E.I.2
  • 107
    • 38949158786 scopus 로고    scopus 로고
    • Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells
    • Wang JW, David DJ, Monckton JE, et al: Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 2008; 28:1374-1384
    • (2008) J Neurosci , vol.28 , pp. 1374-1384
    • Wang, J.W.1    David, D.J.2    Monckton, J.E.3
  • 108
    • 34548402661 scopus 로고    scopus 로고
    • The role of hippocampus in anxiety: Intracerebral infusion studies
    • Engin E, Treit D: The role of hippocampus in anxiety: intracerebral infusion studies. Behav Pharmacol 2007; 18:365-374
    • (2007) Behav Pharmacol , vol.18 , pp. 365-374
    • Engin, E.1    Treit, D.2
  • 109
    • 77649107286 scopus 로고    scopus 로고
    • Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: A randomized, double-blind comparison with sertraline
    • Kasper S, Hajak G, Wulff K, et al: Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry 2010; 71:109-120
    • (2010) J Clin Psychiatry , vol.71 , pp. 109-120
    • Kasper, S.1    Hajak, G.2    Wulff, K.3
  • 110
    • 36048935395 scopus 로고    scopus 로고
    • Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice
    • Kumar A, Singh A: Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Planta Med 2007; 73:1358-1364
    • (2007) Planta Med , vol.73 , pp. 1358-1364
    • Kumar, A.1    Singh, A.2
  • 111
    • 4644260713 scopus 로고    scopus 로고
    • Uncoupling proteins and sleep deprivation
    • Cirelli C, Tononi G: Uncoupling proteins and sleep deprivation. Arch Ital Biol 2004; 142:541-549
    • (2004) Arch Ital Biol , vol.142 , pp. 541-549
    • Cirelli, C.1    Tononi, G.2
  • 112
    • 33746922371 scopus 로고    scopus 로고
    • Changes in brain gene expression after long-term sleep deprivation
    • Cirelli C, Faraguna U, Tononi G: Changes in brain gene expression after long-term sleep deprivation. J Neurochem 2006; 98:1632-1645
    • (2006) J Neurochem , vol.98 , pp. 1632-1645
    • Cirelli, C.1    Faraguna, U.2    Tononi, G.3
  • 113
    • 39749149696 scopus 로고    scopus 로고
    • Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression
    • Szuster-Ciesielska A, Sotwinska M, Stachura A, et al: Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:686-694
    • (2008) Prog Neuropsychopharmacol Biol Psychiatry , vol.32 , pp. 686-694
    • Szuster-Ciesielska, A.1    Sotwinska, M.2    Stachura, A.3
  • 114
    • 77950575478 scopus 로고    scopus 로고
    • Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder
    • Andreazza AC, Shao L, Wang JF, et al: Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 2010; 67:360-368
    • (2010) Arch Gen Psychiatry , vol.67 , pp. 360-368
    • Andreazza, A.C.1    Shao, L.2    Wang, J.F.3
  • 115
    • 79959611025 scopus 로고    scopus 로고
    • Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression
    • Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, et al: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2011; 16:751-762
    • (2011) Mol Psychiatry , vol.16 , pp. 751-762
    • Shelton, R.C.1    Claiborne, J.2    Sidoryk-Wegrzynowicz, M.3
  • 116
    • 79954599845 scopus 로고    scopus 로고
    • Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients
    • Maes M, Ruckoanich P, Chang YS, et al: Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:769-783
    • (2011) Prog Neuropsychopharmacol Biol Psychiatry , vol.35 , pp. 769-783
    • Maes, M.1    Ruckoanich, P.2    Chang, Y.S.3
  • 117
    • 77956549615 scopus 로고    scopus 로고
    • Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness
    • Che Y, Wang JF, Shao L, et al: Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci 2010; 35:296-302
    • (2010) J Psychiatry Neurosci , vol.35 , pp. 296-302
    • Che, Y.1    Wang, J.F.2    Shao, L.3
  • 118
    • 77957724723 scopus 로고    scopus 로고
    • Increased glycogen synthase kinase-3b mRNA level in the hippocampus of patients with major depression: A study using the stanley neuropathology consortium integrative database
    • Oh DH, Park YC, Kim SH: Increased glycogen synthase kinase-3b mRNA level in the hippocampus of patients with major depression: a study using the stanley neuropathology consortium integrative database. Psychiatry Investig 2010; 7:202-207
    • (2010) Psychiatry Investig , vol.7 , pp. 202-207
    • Oh, D.H.1    Park, Y.C.2    Kim, S.H.3
  • 119
    • 51349085199 scopus 로고    scopus 로고
    • Oxidative stress markers in bipolar disorder: A meta-analysis
    • Andreazza AC, Kauer-Sant'anna M, Frey BN, et al: Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008; 111:135-144
    • (2008) J Affect Disord , vol.111 , pp. 135-144
    • Andreazza, A.C.1    Kauer-Sant'anna, M.2    Frey, B.N.3
  • 120
    • 51349132292 scopus 로고    scopus 로고
    • Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia
    • Kunz M, Gama CS, Andreazza AC, et al: Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1677-1681
    • (2008) Prog Neuropsychopharmacol Biol Psychiatry , vol.32 , pp. 1677-1681
    • Kunz, M.1    Gama, C.S.2    Andreazza, A.C.3
  • 121
    • 67749122382 scopus 로고    scopus 로고
    • Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia
    • Wang JF, Shao L, Sun X, et al: Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 2009; 11:523-529
    • (2009) Bipolar Disord , vol.11 , pp. 523-529
    • Wang, J.F.1    Shao, L.2    Sun, X.3
  • 122
    • 79952959359 scopus 로고    scopus 로고
    • Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
    • Clay HB, Sillivan S, Konradi C: Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011; 29:311-324
    • (2011) Int J Dev Neurosci , vol.29 , pp. 311-324
    • Clay, H.B.1    Sillivan, S.2    Konradi, C.3
  • 123
    • 79851513447 scopus 로고    scopus 로고
    • Prolidase activity and its diagnostic performance in bipolar disorder
    • Selek S, Altindag A, Saracoglu G, et al: Prolidase activity and its diagnostic performance in bipolar disorder. J Affect Disord 2011; 129:84-86
    • (2011) J Affect Disord , vol.129 , pp. 84-86
    • Selek, S.1    Altindag, A.2    Saracoglu, G.3
  • 124
    • 79952898791 scopus 로고    scopus 로고
    • Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance
    • Ross BM, Maxwell R, Glen I: Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:446-453
    • (2011) Prog Neuropsychopharmacol Biol Psychiatry , vol.35 , pp. 446-453
    • Ross, B.M.1    Maxwell, R.2    Glen, I.3
  • 125
    • 80052961123 scopus 로고    scopus 로고
    • Morphometric post-mortem studies in bipolar disorder: Possible association with oxidative stress and apoptosis
    • Gigante AD, Young LT, Yatham LN, et al: Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 2011; 14:1075-1089
    • (2011) Int J Neuropsychopharmacol , vol.14 , pp. 1075-1089
    • Gigante, A.D.1    Young, L.T.2    Yatham, L.N.3
  • 126
    • 4644342481 scopus 로고    scopus 로고
    • Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment
    • Atmaca M, Tezcan E, Kuloglu M, et al: Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci 2004; 254:231-235
    • (2004) Eur Arch Psychiatry Clin Neurosci , vol.254 , pp. 231-235
    • Atmaca, M.1    Tezcan, E.2    Kuloglu, M.3
  • 127
    • 28444445972 scopus 로고    scopus 로고
    • Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice
    • Hovatta I, Tennant RS, Helton R, et al: Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 2005; 438:662-666
    • (2005) Nature , vol.438 , pp. 662-666
    • Hovatta, I.1    Tennant, R.S.2    Helton, R.3
  • 128
    • 47749091233 scopus 로고    scopus 로고
    • The impact of high anxiety level on the oxidative status of mouse peripheral blood lymphocytes, granulocytes, and monocytes
    • Rammal H, Bouayed J, Younos C, et al: The impact of high anxiety level on the oxidative status of mouse peripheral blood lymphocytes, granulocytes, and monocytes. Eur J Pharmacol 2008; 589:173-175
    • (2008) Eur J Pharmacol , vol.589 , pp. 173-175
    • Rammal, H.1    Bouayed, J.2    Younos, C.3
  • 129
    • 1642564368 scopus 로고    scopus 로고
    • Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: Implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder
    • Modica-Napolitano JS, Renshaw PF: Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder. Biol Psychiatry 2004; 55:273-277
    • (2004) Biol Psychiatry , vol.55 , pp. 273-277
    • Modica-Napolitano, J.S.1    Renshaw, P.F.2
  • 130
    • 34447132960 scopus 로고    scopus 로고
    • Psychiatric comorbidity in 36 adults with mitochondrial cytopathies
    • Fattal O, Link J, Quinn K, et al: Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr 2007; 12:429-438
    • (2007) CNS Spectr , vol.12 , pp. 429-438
    • Fattal, O.1    Link, J.2    Quinn, K.3
  • 131
    • 79954578338 scopus 로고    scopus 로고
    • Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders
    • Gardner A, Boles RG: Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:730-743
    • (2011) Prog Neuropsychopharmacol Biol Psychiatry , vol.35 , pp. 730-743
    • Gardner, A.1    Boles, R.G.2
  • 132
    • 81955161265 scopus 로고    scopus 로고
    • Mitochondria, oligodendrocytes, and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis
    • Konradi C, Sillivan SE, Clay HB: Mitochondria, oligodendrocytes, and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 2012; 45(1):37-47
    • (2012) Neurobiol Dis , vol.45 , Issue.1 , pp. 37-47
    • Konradi, C.1    Sillivan, S.E.2    Clay, H.B.3
  • 133
    • 8244248453 scopus 로고    scopus 로고
    • Plasma levels of cyclic GMP, immune parameters and depressive status during interferon therapy. A prospective study in Japan
    • Kagaya A, Uchitomi Y, Takezaki E, et al: Plasma levels of cyclic GMP, immune parameters and depressive status during interferon therapy. A prospective study in Japan. Neuropsychobiology 1997; 35:128-131
    • (1997) Neuropsychobiology , vol.35 , pp. 128-131
    • Kagaya, A.1    Uchitomi, Y.2    Takezaki, E.3
  • 134
    • 79954613032 scopus 로고    scopus 로고
    • Cytokines-mediated inflammation and decreased neurogenesis in animal models of depression
    • Song C, Wang H: Cytokines-mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:760-768
    • (2011) Prog Neuropsychopharmacol Biol Psychiatry , vol.35 , pp. 760-768
    • Song, C.1    Wang, H.2
  • 135
    • 79959928927 scopus 로고    scopus 로고
    • Antidepressants and neuroinflammation: Can antidepressants calm glial rage down?
    • Hashioka S: Antidepressants and neuroinflammation: can antidepressants calm glial rage down? Mini Rev Med Chem 2011; 11:555-564
    • (2011) Mini Rev Med Chem , vol.11 , pp. 555-564
    • Hashioka, S.1
  • 136
    • 77950022786 scopus 로고    scopus 로고
    • Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
    • Rao JS, Harry GJ, Rapoport SI, et al: Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2010; 15:384-392
    • (2010) Mol Psychiatry , vol.15 , pp. 384-392
    • Rao, J.S.1    Harry, G.J.2    Rapoport, S.I.3
  • 137
    • 75949107129 scopus 로고    scopus 로고
    • Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients
    • Kim HW, Rapoport SI, Rao JS: Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 2010; 37:596-603
    • (2010) Neurobiol Dis , vol.37 , pp. 596-603
    • Kim, H.W.1    Rapoport, S.I.2    Rao, J.S.3
  • 138
    • 76749098860 scopus 로고    scopus 로고
    • Brain arachidonic acid uptake and turnover: Implications for signaling and bipolar disorder
    • Duncan RE, Bazinet RP: Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder. Curr Opin Clin Nutr Metab Care 2010; 13:130-138
    • (2010) Curr Opin Clin Nutr Metab Care , vol.13 , pp. 130-138
    • Duncan, R.E.1    Bazinet, R.P.2
  • 139
    • 0035037342 scopus 로고    scopus 로고
    • Localization of the melatonin-related receptor in the rodent brain and peripheral tissues
    • Drew JE, Barrett P, Mercer JG, et al: Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J Neuroendocrinol 2001; 13:453-458
    • (2001) J Neuroendocrinol , vol.13 , pp. 453-458
    • Drew, J.E.1    Barrett, P.2    Mercer, J.G.3
  • 140
    • 0028155097 scopus 로고
    • Melatonin receptor distribution in the brain and retina of a lizard, Anolis carolinensis
    • Wiechmann AF, Wirsig-Wiechmann CR: Melatonin receptor distribution in the brain and retina of a lizard, Anolis carolinensis. Brain Behav Evol 1994; 43:26-33
    • (1994) Brain Behav Evol , vol.43 , pp. 26-33
    • Wiechmann, A.F.1    Wirsig-Wiechmann, C.R.2
  • 141
    • 0026066725 scopus 로고
    • Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding
    • Stankov B, Cozzi B, Lucini V, et al: Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding. Neurosci Lett 1991; 133:68-72
    • (1991) Neurosci Lett , vol.133 , pp. 68-72
    • Stankov, B.1    Cozzi, B.2    Lucini, V.3
  • 142
    • 0032556682 scopus 로고    scopus 로고
    • Melatonin receptor subtype expression in human cerebellum
    • Al-Ghoul WM, Herman MD, Dubocovich ML: Melatonin receptor subtype expression in human cerebellum. Neuroreport 1998; 9:4063-4068
    • (1998) Neuroreport , vol.9 , pp. 4063-4068
    • Al-Ghoul, W.M.1    Herman, M.D.2    Dubocovich, M.L.3
  • 143
    • 12344268788 scopus 로고    scopus 로고
    • Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease
    • Savaskan E, Ayoub MA, Ravid R, et al: Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. J Pineal Res 2005; 38:10-16
    • (2005) J Pineal Res , vol.38 , pp. 10-16
    • Savaskan, E.1    Ayoub, M.A.2    Ravid, R.3
  • 144
    • 49549085247 scopus 로고    scopus 로고
    • Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress
    • Das A, Belagodu A, Reiter RJ, et al: Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J Pineal Res 2008; 45:117-124
    • (2008) J Pineal Res , vol.45 , pp. 117-124
    • Das, A.1    Belagodu, A.2    Reiter, R.J.3
  • 145
    • 51649122290 scopus 로고    scopus 로고
    • Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescenceaccelerated mice
    • Caballero B, Vega-Naredo I, Sierra V, et al: Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescenceaccelerated mice. J Pineal Res 2008; 45:302-311
    • (2008) J Pineal Res , vol.45 , pp. 302-311
    • Caballero, B.1    Vega-Naredo, I.2    Sierra, V.3
  • 146
    • 75149124310 scopus 로고    scopus 로고
    • The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors
    • Das A, McDowell M, Pava MJ, et al: The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res 2010; 48:157-169
    • (2010) J Pineal Res , vol.48 , pp. 157-169
    • Das, A.1    McDowell, M.2    Pava, M.J.3
  • 147
    • 79960383133 scopus 로고    scopus 로고
    • Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors
    • Choi SI, Dadakhujaev S, Ryu H, et al: Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J Pineal Res 2011; 51:94-103
    • (2011) J Pineal Res , vol.51 , pp. 94-103
    • Choi, S.I.1    Dadakhujaev, S.2    Ryu, H.3
  • 148
    • 79954631683 scopus 로고    scopus 로고
    • Nitric oxide and major depression
    • Dhir A, Kulkarni SK: Nitric oxide and major depression. Nitric Oxide 2011; 24:125-131
    • (2011) Nitric Oxide , vol.24 , pp. 125-131
    • Dhir, A.1    Kulkarni, S.K.2
  • 149
    • 39649109917 scopus 로고    scopus 로고
    • The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode
    • Selek S, Savas HA, Gergerlioglu HS, et al: The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 2008; 107:89-94
    • (2008) J Affect Disord , vol.107 , pp. 89-94
    • Selek, S.1    Savas, H.A.2    Gergerlioglu, H.S.3
  • 150
    • 0036720341 scopus 로고    scopus 로고
    • Melatonin reduces nonadrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro
    • Storr M, Koppitz P, Sibaev A, et al: Melatonin reduces nonadrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro. J Pineal Res 2002; 33: 101-108
    • (2002) J Pineal Res , vol.33 , pp. 101-108
    • Storr, M.1    Koppitz, P.2    Sibaev, A.3
  • 151
    • 77949746666 scopus 로고    scopus 로고
    • The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity
    • Castrén E, Rantamäki T: The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol 2010; 70:289-297
    • (2010) Dev Neurobiol , vol.70 , pp. 289-297
    • Castrén, E.1    Rantamäki, T.2
  • 152
    • 77955078119 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
    • Hashimoto K: Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 2010; 64:341-357
    • (2010) Psychiatry Clin Neurosci , vol.64 , pp. 341-357
    • Hashimoto, K.1
  • 153
    • 78651076464 scopus 로고    scopus 로고
    • The role of BDNF in depression on the basis of its location in the neural circuitry
    • Yu H, Chen ZY: The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin 2011; 32:3-11
    • (2011) Acta Pharmacol Sin , vol.32 , pp. 3-11
    • Yu, H.1    Chen, Z.Y.2
  • 154
    • 79551638797 scopus 로고    scopus 로고
    • The role of BDNF as a mediator of neuroplasticity in bipolar disorder
    • Grande I, Fries GR, Kunz M, et al: The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 2010; 7:243-250
    • (2010) Psychiatry Investig , vol.7 , pp. 243-250
    • Grande, I.1    Fries, G.R.2    Kunz, M.3
  • 155
    • 79958747390 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis
    • Fernandes BS, Gama CS, Ceresér KM, et al: Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 2011; 45:995-1004
    • (2011) J Psychiatr Res , vol.45 , pp. 995-1004
    • Fernandes, B.S.1    Gama, C.S.2    Ceresér, K.M.3
  • 156
    • 44649165647 scopus 로고    scopus 로고
    • Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells
    • Imbesi M, Uz T, Dzitoyeva S, et al: Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells. Neurosci Lett 2008; 439:34-36
    • (2008) Neurosci Lett , vol.439 , pp. 34-36
    • Imbesi, M.1    Uz, T.2    Dzitoyeva, S.3
  • 157
    • 77649107717 scopus 로고    scopus 로고
    • Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration
    • Molteni R, Calabrese F, Pisoni S, et al: Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration. World J Biol Psychiatry 2010; 11:148-153
    • (2010) World J Biol Psychiatry , vol.11 , pp. 148-153
    • Molteni, R.1    Calabrese, F.2    Pisoni, S.3
  • 158
    • 0036720357 scopus 로고    scopus 로고
    • Receptor (MT(1) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1
    • Peschke E, Mühlbauer E, Musshoff U, et al: Receptor (MT(1) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 2002; 33:63-71
    • (2002) J Pineal Res , vol.33 , pp. 63-71
    • Peschke, E.1    Mühlbauer, E.2    Musshoff, U.3
  • 159
    • 0019782129 scopus 로고
    • Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression
    • Lerer B, Ebstein RP, Belmaker RH: Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression. Psychopharmacology (Berl) 1981; 75:169-172
    • (1981) Psychopharmacology (Berl) , vol.75 , pp. 169-172
    • Lerer, B.1    Ebstein, R.P.2    Belmaker, R.H.3
  • 160
    • 62149117324 scopus 로고    scopus 로고
    • Chronic imipramine downregulates cyclic AMP signaling in rat hippocampus
    • Reierson GW, Mastronardi CA, Licinio J, et al: Chronic imipramine downregulates cyclic AMP signaling in rat hippocampus. Neuroreport 2009; 20:307-311
    • (2009) Neuroreport , vol.20 , pp. 307-311
    • Reierson, G.W.1    Mastronardi, C.A.2    Licinio, J.3
  • 161
    • 28844473025 scopus 로고    scopus 로고
    • Novel targets for valproic acid: Up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells
    • Castro LM, Gallant M, Niles LP: Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J Neurochem 2005; 95:1227-1236
    • (2005) J Neurochem , vol.95 , pp. 1227-1236
    • Castro, L.M.1    Gallant, M.2    Niles, L.P.3
  • 162
    • 43049123138 scopus 로고    scopus 로고
    • Melatonin regulates the viability and differentiation of rat midbrain neural stem cells
    • Kong X, Li X, Cai Z, et al: Melatonin regulates the viability and differentiation of rat midbrain neural stem cells. Cell Mol Neurobiol 2008; 28:569-579
    • (2008) Cell Mol Neurobiol , vol.28 , pp. 569-579
    • Kong, X.1    Li, X.2    Cai, Z.3
  • 163
    • 51449102968 scopus 로고    scopus 로고
    • Altered glial cell linederived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: A comparative post-mortem study
    • Michel TM, Frangou S, Camara S, et al: Altered glial cell linederived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry 2008; 23:413-420
    • (2008) Eur Psychiatry , vol.23 , pp. 413-420
    • Michel, T.M.1    Frangou, S.2    Camara, S.3
  • 164
    • 79960291275 scopus 로고    scopus 로고
    • Association study between plasma GDNF and cognitive function in late-onset depression
    • Wang X, Hou Z, Yuan Y, et al: Association study between plasma GDNF and cognitive function in late-onset depression. J Affect Disord 2011; 132:418-421
    • (2011) J Affect Disord , vol.132 , pp. 418-421
    • Wang, X.1    Hou, Z.2    Yuan, Y.3
  • 165
    • 80054115722 scopus 로고    scopus 로고
    • Ndesalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells:A putative cellularmechanism for quetiapine as antidepressant
    • Di Benedetto B, Kühn R, Nothdurfter C, et al: Ndesalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells:A putative cellularmechanism for quetiapine as antidepressant. Neuropharmacology 2012; 62(1):209-216
    • (2012) Neuropharmacology , vol.62 , Issue.1 , pp. 209-216
    • Di Benedetto, B.1    Kühn, R.2    Nothdurfter, C.3
  • 166
    • 12944335008 scopus 로고    scopus 로고
    • Neural stem cells express melatonin receptors and neurotrophic factors: Colocalization of the MT1 receptor with neuronal and glial markers
    • Niles LP, Armstrong KJ, Rincón Castro LM, et al: Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci 2004; 5:41
    • (2004) BMC Neurosci , vol.5 , pp. 41
    • Niles, L.P.1    Armstrong, K.J.2    Rincón Castro, L.M.3
  • 167
    • 0020986403 scopus 로고
    • Dopamine and depression: A review of recent evidence. I. Empirical studies
    • Willner P: Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res 1983; 287:211-224
    • (1983) Brain Res , vol.287 , pp. 211-224
    • Willner, P.1
  • 169
    • 33746900423 scopus 로고    scopus 로고
    • The mesolimbic dopamine reward circuit in depression
    • Nestler EJ, Carlezon WA Jr: The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59:1151-1159
    • (2006) Biol Psychiatry , vol.59 , pp. 1151-1159
    • Nestler, E.J.1    Carlezon Jr., W.A.2
  • 170
    • 0034756697 scopus 로고    scopus 로고
    • Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls
    • Neumeister A, Willeit M, Praschak-Rieder N, et al: Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med 2001; 31:1467-1473
    • (2001) Psychol Med , vol.31 , pp. 1467-1473
    • Neumeister, A.1    Willeit, M.2    Praschak-Rieder, N.3
  • 171
    • 0029835266 scopus 로고    scopus 로고
    • Dopamine and circadian rhythms in seasonal affective disorder
    • Partonen T: Dopamine and circadian rhythms in seasonal affective disorder. Med Hypotheses 1996; 47:191-192
    • (1996) Med Hypotheses , vol.47 , pp. 191-192
    • Partonen, T.1
  • 172
    • 57149127712 scopus 로고    scopus 로고
    • The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro
    • Imbesi M, Arslan AD, Yildiz S, et al: The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro. J Pineal Res 2009; 46:87-94
    • (2009) J Pineal Res , vol.46 , pp. 87-94
    • Imbesi, M.1    Arslan, A.D.2    Yildiz, S.3
  • 173
    • 77956263606 scopus 로고    scopus 로고
    • Altered expression of circadian rhythm genes among individuals with a history of depression
    • Gouin JP, Connors J, Kiecolt-Glaser JK, et al: Altered expression of circadian rhythm genes among individuals with a history of depression. J Affect Disord 2010; 126:161-166
    • (2010) J Affect Disord , vol.126 , pp. 161-166
    • Gouin, J.P.1    Connors, J.2    Kiecolt-Glaser, J.K.3
  • 174
    • 77951113131 scopus 로고    scopus 로고
    • Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder
    • Soria V, Martínez-Amorós E, Escaramís G, et al: Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 2010; 35:1279-1289
    • (2010) Neuropsychopharmacology , vol.35 , pp. 1279-1289
    • Soria, V.1    Martínez-Amorós, E.2    Escaramís, G.3
  • 175
    • 34447546856 scopus 로고    scopus 로고
    • Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression
    • Benedetti F, Dallaspezia S, Fulgosi MC, et al: Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:631-635
    • (2007) Am J Med Genet B Neuropsychiatr Genet , vol.144 B , pp. 631-635
    • Benedetti, F.1    Dallaspezia, S.2    Fulgosi, M.C.3
  • 176
    • 0142188193 scopus 로고    scopus 로고
    • Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression
    • Benedetti F, Serretti A, Colombo C, et al: Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2003; 123B:23-26
    • (2003) Am J Med Genet B Neuropsychiatr Genet , vol.123 B , pp. 23-26
    • Benedetti, F.1    Serretti, A.2    Colombo, C.3
  • 177
    • 34247634564 scopus 로고    scopus 로고
    • Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression
    • Partonen T, Treutlein J, Alpman A, et al: Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med 2007; 39:229-238
    • (2007) Ann Med , vol.39 , pp. 229-238
    • Partonen, T.1    Treutlein, J.2    Alpman, A.3
  • 178
    • 0038727151 scopus 로고    scopus 로고
    • Circadian clockrelated polymorphisms in seasonal affective disorder and their relevance to diurnal preference
    • Johansson C, Willeit M, Smedh C, et al: Circadian clockrelated polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 2003; 28:734-739
    • (2003) Neuropsychopharmacology , vol.28 , pp. 734-739
    • Johansson, C.1    Willeit, M.2    Smedh, C.3
  • 179
    • 78650800876 scopus 로고    scopus 로고
    • MT2 receptors mediate the inhibitory effects of melatonin on nitric oxideinduced relaxation of porcine isolated coronary arteries
    • Tunstall RR, Shukla P, Grazul-Bilska A, et al: MT2 receptors mediate the inhibitory effects of melatonin on nitric oxideinduced relaxation of porcine isolated coronary arteries. J Pharmacol Exp Ther 2011; 336:127-133
    • (2011) J Pharmacol Exp Ther , vol.336 , pp. 127-133
    • Tunstall, R.R.1    Shukla, P.2    Grazul-Bilska, A.3
  • 180
    • 0242269986 scopus 로고    scopus 로고
    • Melatonin prevents apoptosis and enhances HSP27 mRNA expression induced by heat shock in HL-60 cells: Possible involvement of the MT2 receptor
    • Cabrera J, Quintana J, Reiter RJ, et al: Melatonin prevents apoptosis and enhances HSP27 mRNA expression induced by heat shock in HL-60 cells: possible involvement of the MT2 receptor. J Pineal Res 2003; 35:231-238
    • (2003) J Pineal Res , vol.35 , pp. 231-238
    • Cabrera, J.1    Quintana, J.2    Reiter, R.J.3
  • 181
    • 34249009631 scopus 로고    scopus 로고
    • Signs of apoptosis of immunocompetent cells in patients with depression
    • Ivanova SA, Semke VY, Vetlugina TP, et al: Signs of apoptosis of immunocompetent cells in patients with depression. Neurosci Behav Physiol 2007; 37:527-530
    • (2007) Neurosci Behav Physiol , vol.37 , pp. 527-530
    • Ivanova, S.A.1    Semke, V.Y.2    Vetlugina, T.P.3
  • 182
    • 67650470151 scopus 로고    scopus 로고
    • "Killing the Blues": A role for cellular suicide (apoptosis) in depression and the antidepressant response?
    • McKernan DP, Dinan TG, Cryan JF: "Killing the Blues": a role for cellular suicide (apoptosis) in depression and the antidepressant response? Prog Neurobiol 2009; 88:246-263
    • (2009) Prog Neurobiol , vol.88 , pp. 246-263
    • McKernan, D.P.1    Dinan, T.G.2    Cryan, J.F.3
  • 183
    • 84856693660 scopus 로고    scopus 로고
    • Extrapineal melatonin: Analysis of its subcellular distribution and daily fluctuations
    • Venegas C, García JA, Escames G, et al: Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2011; 52:217-227
    • (2011) J Pineal Res , vol.52 , pp. 217-227
    • Venegas, C.1    García, J.A.2    Escames, G.3
  • 184
    • 80052849856 scopus 로고    scopus 로고
    • Agomelatine: A narrative review
    • Demyttenaere K: Agomelatine: a narrative review. Eur Neuropsychopharmacol 2011; 21(Suppl 4):S703-S709
    • (2011) Eur Neuropsychopharmacol , vol.21 , Issue.SUPPL. 4
    • Demyttenaere, K.1
  • 186
    • 34948841405 scopus 로고    scopus 로고
    • Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder
    • Olié JP, Kasper S: Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol 2007; 10(5): 661-673
    • (2007) Int J Neuropsychopharmacol , vol.10 , Issue.5 , pp. 661-673
    • Olié, J.P.1    Kasper, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.